Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 127

1.

Moderation of herpetic stromal keratitis by basic fibroblast growth factor.

Gamus D, Romano A, Rubinstein M, Savion N.

Exp Eye Res. 1996 Jul;63(1):1-8.

PMID:
8983954
2.

Treatment with meliacine, a plant derived antiviral, prevents the development of herpetic stromal keratitis in mice.

Alché LE, Berra A, Veloso MJ, Coto CE.

J Med Virol. 2000 Aug;61(4):474-80.

PMID:
10897066
3.

Basic fibroblast growth factor modulates corneal wound healing after excimer laser keratomileusis in rabbits.

Rieck P, David T, Hartmann C, Renard G, Courtois Y, Pouliquen Y.

Ger J Ophthalmol. 1994 Mar;3(2):105-11.

PMID:
8193570
4.

Persistence of herpes simplex virus DNA in rabbit corneal cells.

Cantin E, Chen J, Willey DE, Taylor JL, O'Brien WJ.

Invest Ophthalmol Vis Sci. 1992 Jul;33(8):2470-5.

PMID:
1321797
5.

PCR assessment of HSV-1 corneal infection in animals treated with rose bengal and lissamine green B.

Stroop WG, Chen TM, Chodosh J, Kienzle TE, Stroop JL, Ling JY, Miles DA.

Invest Ophthalmol Vis Sci. 2000 Jul;41(8):2096-102.

PMID:
10892849
6.

Bilateral herpetic keratoconjunctivitis.

Souza PM, Holland EJ, Huang AJ.

Ophthalmology. 2003 Mar;110(3):493-6.

PMID:
12623810
7.

Glycoprotein C of herpes simplex virus type 1 is required to cause keratitis at low infectious doses in intact rabbit corneas.

Drolet BS, Mott KR, Lippa AM, Wechsler SL, Perng GC.

Curr Eye Res. 2004 Aug-Sep;29(2-3):181-9.

PMID:
15512965
8.

Herpes simplex keratitis.

Kaye S, Choudhary A.

Prog Retin Eye Res. 2006 Jul;25(4):355-80. Epub 2006 Jun 27. Review.

PMID:
16807055
9.

Effect of oral valaciclovir on herpetic keratitis.

Higaki S, Itahashi M, Deai T, Fukuda M, Shimomura Y.

Cornea. 2006 Dec;25(10 Suppl 1):S64-7.

PMID:
17001196
10.

In vitro and in vivo effects of polyhexamethylene biguanide against herpes simplex virus infection.

Valluri S, Fleming TP, Laycock KA, Tarle IS, Goldberg MA, Garcia-Ferrer FJ, Essary LR, Pepose JS.

Cornea. 1997 Sep;16(5):556-9.

PMID:
9294689
11.

Improvement of HSV-1 necrotizing keratitis with amniotic membrane transplantation.

Heiligenhaus A, Bauer D, Meller D, Steuhl KP, Tseng SC.

Invest Ophthalmol Vis Sci. 2001 Aug;42(9):1969-74.

PMID:
11481259
12.

[Suppression effects of interleukin-10 on mouse herpetic stromal keratitis].

Xia LK, Gao DW, Pu W, Zhang JS.

Zhonghua Yan Ke Za Zhi. 2003 Oct;39(10):592-6. Chinese.

PMID:
14766072
13.

Basic fibroblast growth factor stimulates epithelial cell growth and epithelial wound healing in canine corneas.

Hu C, Ding Y, Chen J, Liu D, Zhang Y, Ding M, Wang G.

Vet Ophthalmol. 2009 May-Jun;12(3):170-5. doi: 10.1111/j.1463-5224.2009.00696.x.

PMID:
19392876
14.

Incidence and severity of herpetic stromal keratitis: impaired by the depletion of lymph node macrophages.

Bauer D, Mrzyk S, Van Rooijen N, Steuhl KP, Heiligenhaus A.

Exp Eye Res. 2001 Mar;72(3):261-9.

PMID:
11180975
15.
16.

The antimicrobial agent C31G is effective for therapy for HSV-1 ocular keratitis in the rabbit eye model.

Hill JM, Stern EM, Bhattacharjee PS, Malamud D, Clement C, Rodriguez P, Lukiw WJ, Ochoa AC, Foster TP, Velasco C, McFerrin HE Jr.

Antiviral Res. 2013 Oct;100(1):14-9. doi: 10.1016/j.antiviral.2013.07.002. Epub 2013 Jul 13.

17.

Ocular inoculation of monkeys with simian varicella virus: clinical and histopathologic observations.

Metcalf JF, Christianson MD, Brady AG.

Invest Ophthalmol Vis Sci. 1995 Jan;36(1):41-51.

PMID:
7822158
18.

Effect of topical cyclosporin A on herpetic stromal keratitis in a mouse model.

Yoon KC, Heo H, Kang IS, Lee MC, Kim KK, Park SH, Cho KO.

Cornea. 2008 May;27(4):454-60. doi: 10.1097/ICO.0b013e318160602d.

PMID:
18434850
19.

Effects of cyclosporine A on clinical and immunological parameters in herpes simplex keratitis.

Meyers-Elliott RH, Chitjian PA, Billups CB.

Invest Ophthalmol Vis Sci. 1987 Jul;28(7):1170-80.

PMID:
3036742
20.

Herpes simplex virus-specific T cells infiltrate the cornea of patients with herpetic stromal keratitis: no evidence for autoreactive T cells.

Verjans GM, Remeijer L, Mooy CM, Osterhaus AD.

Invest Ophthalmol Vis Sci. 2000 Aug;41(9):2607-12.

PMID:
10937573

Supplemental Content

Support Center